Inhibitors of DNA Precursor Metabolism in Dictyostelium discoideum
Abstract
Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» Information about commercial reprint orders: http://aac.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ ERRATA Alpha Interferon and Acyclovir Treatment of Herpes Simplex Virus in Lymphoid Cell Cultures SCOTT M. HAMMER, JOAN C. KAPLAN, BRUCE R. LOWE, AND MARTIN S. HIRSCH Infectious Disease Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114 Downloaded from http://aac.asm.org/ on November 20, 2011 by deepdyve Volume 21, no. 4, page 636: Figures 1 and 2 should be interchanged. Pharmacokinetics of Cefonicid, a New Broad-Spectrum Cephalosporin STEVEN L-. BARRIERE, GERARD J. HATHEWAY, JOHN G. GAMBERTOGLIO, EMIL T. LIN, AND JOHN E. CONTE, JR. Infectious Diseases Research Unit: Division of Clinical Pharmacy, Department of Pharmacy, School of Pharmacy, and the Clinical Infectious Diseases Unit, Department of Medicine, University of California, San Francisco, California 94143 Volume 21, no. 6, p. 937, column 2, line 50: "Conceivably, systemic infections may be adequately treated with doses of cefonicid given every 12 h" should read "Recent unpublished clinical trials using larger doses of cefonicid (1 to 2 g) than administered herein have demonstrated that single daily administration